BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 24985565)

  • 1. Kinetics and mechanism of the base-catalyzed rearrangement and hydrolysis of ezetimibe.
    Baťová J; Imramovský A; HájÍček J; Hejtmánková L; Hanusek J
    J Pharm Sci; 2014 Aug; 103(8):2240-7. PubMed ID: 24985565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acid-base catalysis of N-[(morpholine)methylene]daunorubicin.
    Krause A; Jelińska A; Cielecka-Piontek J; Klawitter M; Zalewski P; Oszczapowicz I; Wąsowska M
    Drug Dev Ind Pharm; 2012 Aug; 38(8):1024-8. PubMed ID: 22124459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a novel stability-indicating HPLC method for the quantitative determination of eleven related substances in ezetimibe drug substance and drug product.
    Luo Z; Deng Z; Liu Y; Wang G; Yang W; Hou C; Tang M; Yang R; Zhou H
    Talanta; 2015 Jul; 139():67-74. PubMed ID: 25882410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mechanistic and kinetic study of the beta-lactone hydrolysis of Salinosporamide A (NPI-0052), a novel proteasome inhibitor.
    Denora N; Potts BC; Stella VJ
    J Pharm Sci; 2007 Aug; 96(8):2037-47. PubMed ID: 17554770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aminolysis of ezetimibe.
    Baťová J; Imramovský A; Hanusek J
    J Pharm Biomed Anal; 2015 Mar; 107():495-500. PubMed ID: 25686539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics and mechanism of the hydrolytic degradation of indinavir: intramolecular catalysis.
    Toteva MM; Zanon R; Ostovic D
    J Pharm Sci; 2008 Sep; 97(9):3810-9. PubMed ID: 18186489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What is the degradation product of ezetimibe?
    Barhate CR; Mohanraj K
    J Pharm Biomed Anal; 2011 Jul; 55(5):1237-8. PubMed ID: 21450427
    [No Abstract]   [Full Text] [Related]  

  • 8. Stability of ertapenem in aqueous solutions.
    Zajac M; Cielecka-Piontek J; Jelińska A
    J Pharm Biomed Anal; 2007 Jan; 43(2):445-9. PubMed ID: 16914282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability of ricobendazole in aqueous solutions.
    Wu Z; Tucker IG; Razzak M; Medlicott NJ
    J Pharm Biomed Anal; 2009 Jul; 49(5):1282-6. PubMed ID: 19342190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydrolytic products and kinetics of triazophos in buffered and alkaline solutions with different values of pH.
    Kunde L; Dongxing Y; Yongzhi D; Meng C
    J Agric Food Chem; 2004 Aug; 52(17):5404-11. PubMed ID: 15315377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of human UDP-glucuronosyltransferase enzyme(s) responsible for the glucuronidation of ezetimibe (Zetia).
    Ghosal A; Hapangama N; Yuan Y; Achanfuo-Yeboah J; Iannucci R; Chowdhury S; Alton K; Patrick JE; Zbaida S
    Drug Metab Dispos; 2004 Mar; 32(3):314-20. PubMed ID: 14977865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Degradation kinetics and mechanism of aminocephalosporins in aqueous solution: cefadroxil.
    Tsuji A; Nakashima E; Deguchi Y; Nishide K; Shimizu T; Horiuchi S; Ishikawa K; Yamana T
    J Pharm Sci; 1981 Oct; 70(10):1120-8. PubMed ID: 7299645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and structure elucidation of major alkaline degradant of ezetimibe.
    Gajjar AK; Shah VD
    J Pharm Biomed Anal; 2011 Apr; 55(1):225-9. PubMed ID: 21288678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of the major degradant of ezetimibe.
    Sánta Z; Kóti J; Szoke K; Vukics K; Szántay C
    J Pharm Biomed Anal; 2012 Jan; 58():125-9. PubMed ID: 21978828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of pH, temperature and buffers on the degradation kinetics of cefetamet pivoxil hydrochloride in aqueous solutions.
    Jelińska A; Dobrowolski L; Oszczapowicz I
    J Pharm Biomed Anal; 2004 Sep; 35(5):1273-7. PubMed ID: 15336372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of hydrolysis of 4-methoxy-2-[2-hydroxy-3(4-phenyl-1-piperazinyl)]propyl-2,3-dihydro-6-methyl-1,3-dioxo-1H-pyrrolo[3,4-c]pyridine in aqueous solutions.
    Muszalska I
    Farmaco; 2004 Jun; 59(6):437-42. PubMed ID: 15178305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics and mechanism of hydrolysis of efavirenz.
    Maurin MB; Rowe SM; Blom K; Pierce ME
    Pharm Res; 2002 Apr; 19(4):517-21. PubMed ID: 12033389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isoxazoles. VII: Hydrolysis of 4-methyl-5-isoxazolylnaphthoquinone derivatives in aqueous solutions.
    Longhi MR; de Bertorello MM; Briñón MC
    J Pharm Sci; 1991 Jun; 80(6):573-7. PubMed ID: 1941551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification, isolation and characterization of process related impurities in ezetimibe.
    Guntupalli S; Ray UK; Murali N; Gupta PB; Kumar VJ; Satheesh D; Islam A
    J Pharm Biomed Anal; 2014 Jan; 88():385-90. PubMed ID: 24176742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of new analgesic active compound, pyrrolo-[3,4-c]pyridine derivative, in aqueous solutions.
    Muszalska I; Wojtyniak E
    Acta Pol Pharm; 2007; 64(4):319-25. PubMed ID: 18536157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.